Foresite Capital Management II’s Insmed INSM Stock Holding History

Foresite Capital Management II’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-236,547	Closed	-$3.79M	–	4
2020 Q1	$3.79M	Sell	236,547 -643,469	-73%	-$15.3M	0.89%	3
2019 Q4	$21M	Sell	880,016 -35,000	-4%	-$712K	3.46%	3
2019 Q3	$16.1M	Sell	915,016 -40,446	-4%	-$781K	3.41%	4
2019 Q2	$24.5M	Buy	955,462 +36,026	+4%	+$1M	13.75%	3
2019 Q1	$26.7M	Sell	919,436 -48,200	-5%	-$1.25M	12.07%	3
2018 Q4	$12.7M	Hold	967,636	–	–	6.73%	4
2018 Q3	$19.6M	Hold	967,636	–	–	7.24%	4
2018 Q2	$22.9M	Hold	967,636	–	–	8.06%	4
2018 Q1	$21.8M	Buy	967,636 +448,991	+87%	+$11.8M	7.25%	4
2017 Q4	$16.2M	Buy	518,645 +218,645	+73%	+$6.46M	5.65%	4
2017 Q3	$9.36M	Buy	+300,000	New	+$5.71M	3.8%	5

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Foresite Capital Management II's INSM Position: Q2 2020 in Review

Foresite Capital Management II sold out of Insmed (INSM) in Q2 2020, closing a stake of 236,547 shares — an estimated $3.79M sold.

Foresite Capital Management II first reported a position in INSM in Q3 2017 and held it in 11 quarters. The position peaked at $26.7M in Q1 2019. 191 funds tracked by Wall St. Rank hold INSM as of Q2 2020.

Foresite Capital Management II reported no remaining Insmed position as of Q2 2020 after selling out during the quarter.
Foresite Capital Management II sold 236,547 Insmed shares in Q2 2020, an estimated $3.79M.
Foresite Capital Management II first reported a position in Insmed in Q3 2017 and held it in 11 quarters.
Foresite Capital Management II's Insmed position peaked at $26.7M in Q1 2019.
191 funds tracked by Wall St. Rank held Insmed as of Q2 2020.

Based on Foresite Capital Management II's 13F filing for Q2 2020, filed 13 Aug 2020.